Nhut Le

785 total citations
24 papers, 588 citations indexed

About

Nhut Le is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Nhut Le has authored 24 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Virology, 17 papers in Infectious Diseases and 7 papers in Immunology. Recurrent topics in Nhut Le's work include HIV Research and Treatment (21 papers), HIV/AIDS drug development and treatment (17 papers) and Immune Cell Function and Interaction (6 papers). Nhut Le is often cited by papers focused on HIV Research and Treatment (21 papers), HIV/AIDS drug development and treatment (17 papers) and Immune Cell Function and Interaction (6 papers). Nhut Le collaborates with scholars based in United States, Nigeria and Canada. Nhut Le's co-authors include Alonso Heredia, Robert Redfield, Robert C. Gallo, Charles E. Davis, Olga Latinovic, Mohammad M. Sajadi, Anthony L. DeVico, Juan Carlos Zapata, Sandra Medina-Moreno and Edward A. Sausville and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and The Journal of Infectious Diseases.

In The Last Decade

Nhut Le

23 papers receiving 581 citations

Peers

Countries citing papers authored by Nhut Le

Since Specialization

Citations

This map shows the geographic impact of Nhut Le's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nhut Le with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nhut Le more than expected).

Fields of papers citing papers by Nhut Le

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nhut Le. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nhut Le. The network helps show where Nhut Le may publish in the future.

Co-authorship network of co-authors of Nhut Le

This figure shows the co-authorship network connecting the top 25 collaborators of Nhut Le. A scholar is included among the top collaborators of Nhut Le based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nhut Le. Nhut Le is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Investigation on Phytochemicals and Nutritional Values of Three Passion Fruit Species Planted in Lam Dong Plateau 2024 ·(unknown), Nhut Le	0
2	Human Hematopoietic Stem Cell (HSC)-Engrafted NSG Mice for HIV Latency Research 2022 ·Methods in molecular biology ·(unknown), Nhut Le, Alonso Heredia	2
3	Targeting of CDK9 with indirubin 3’-monoxime safely and durably reduces HIV viremia in chronically infected humanized mice 2017 ·PLoS ONE ·Sandra Medina-Moreno, Thomas C. Dowling, Juan Carlos Zapata, Nhut Le, Edward A. Sausville, Joseph Bryant, Robert Redfield, Alonso Heredia	16
4	Monotherapy with either dolutegravir or raltegravir fails to durably suppress HIV viraemia in humanized mice 2017 ·Journal of Antimicrobial Chemotherapy ·Alonso Heredia, Said Hassounah, Sandra Medina-Moreno, Juan Carlos Zapata, Nhut Le, Ying-Shan Han, James S. Foulke, Charles C. Davis, Joseph Bryant, Robert Redfield, Mark A. Wainberg	12
5	Targeting of mTOR catalytic site inhibits multiple steps of the HIV-1 lifecycle and suppresses HIV-1 viremia in humanized mice 2015 ·Proceedings of the National Academy of Sciences ·Alonso Heredia, Nhut Le, Ronald B. Gartenhaus, Edward A. Sausville, Sandra Medina-Moreno, Juan Carlos Zapata, Charles E. Davis, Robert C. Gallo, Robert Redfield	79
6	Targeting of the Purine Biosynthesis Host Cell Pathway Enhances the Activity of Tenofovir Against Sensitive and Drug-Resistant HIV-1 2013 ·The Journal of Infectious Diseases ·Alonso Heredia, Charles E. Davis, M S Reitz, Nhut Le, Mark A. Wainberg, James S. Foulke, Lai‐Xi Wang, Robert Redfield	14
7	Targeting host nucleotide biosynthesis with resveratrol inhibits emtricitabine-resistant HIV-1 2013 ·AIDS ·Alonso Heredia, Charles E. Davis, Mohammed A. Amin, Nhut Le, Mark A. Wainberg, Maureen Oliveira, Steven G. Deeks, Lai‐Xi Wang, Robert Redfield	22
8	CCR5 antibodies HGS004 and HGS101 preferentially inhibit drug-bound CCR5 infection and restore drug sensitivity of Maraviroc-resistant HIV-1 in primary cells 2011 ·Virology ·Olga Latinovic, Marvin S. Reitz, Nhut Le, James S. Foulke, Gerd Fätkenheuer, Clara Lehmann, Robert R. Redfield, Alonso Heredia	15
9	Synergistic inhibition of R5 HIV-1 by maraviroc and CCR5 antibody HGS004 in primary cells: implications for treatment and prevention 2011 ·AIDS ·Olga Latinovic, Nhut Le, Marvin S. Reitz, Ranajit Pal, Anthony L. DeVico, James S. Foulke, Robert Redfield, Alonso Heredia	11
10	Rapamycin enhances aplaviroc anti-HIV activity: Implications for the clinical development of novel CCR5 antagonists 2009 ·Antiviral Research ·Olga Latinovic, Alonso Heredia, Richard L. Gallo, (unknown), Nhut Le, Robert Redfield	13
11	Pharmacotherapy of HIV-1 Infection: Focus on CCR5 Antagonist Maraviroc 2009 ·PubMed ·Olga Latinovic, Janaki Kuruppu, Charles E. Davis, Nhut Le, Alonso Heredia	22
12	HIV-1 natural viral suppressors: control of viral replication in the absence of therapy 2007 ·AIDS ·Mohammad M. Sajadi, Alonso Heredia, Nhut Le, (unknown), Robert Redfield	68
13	CCR5 density levels on primary CD4 T cells impact the replication and Enfuvirtide susceptibility of R5 HIV-1 2007 ·AIDS ·Alonso Heredia, Bruce L. Gilliam, Anthony L. DeVico, Nhut Le, (unknown), Robin Flinko, George K. Lewis, Robert C. Gallo, Robert Redfield	36
14	Rapamycin Reduces CCR5 Density Levels on CD4 T Cells, and This Effect Results in Potentiation of Enfuvirtide (T-20) against R5 Strains of Human Immunodeficiency Virus Type 1 In Vitro 2007 ·Antimicrobial Agents and Chemotherapy ·Alonso Heredia, Bruce L. Gilliam, Olga Latinovic, Nhut Le, (unknown), Anthony L. DeVico, Gregory B. Melikyan, Robert C. Gallo, Robert Redfield	24
15	Rapamycin reduces CCR5 mRNA levels in macaques: potential applications in HIV-1 prevention and treatment 2007 ·AIDS ·Bruce L. Gilliam, Alonso Heredia, Anthony L. DeVico, Nhut Le, (unknown), Joseph Bryant, C. David Pauza, Robert R. Redfield	28
16	Modification and structure–activity relationship of a small molecule HIV-1 inhibitor targeting the viral envelope glycoprotein gp120 2005 ·Organic & Biomolecular Chemistry ·Jingsong Wang, Nhut Le, Alonso Heredia, Haijing Song, Robert Redfield, Lai‐Xi Wang	24
17	In vitro suppression of latent HIV-1 activation by vitamin E: potential clinical implications 2005 ·AIDS ·Alonso Heredia, Charles E. Davis, Anthony Amoroso, (unknown), Nhut Le, (unknown), Robert Redfield	5
18	Indirubin-3′-monoxime, a derivative of a Chinese antileukemia medicine, inhibits P-TEFb function and HIV-1 replication 2005 ·AIDS ·Alonso Heredia, Charles E. Davis, (unknown), Nhut Le, (unknown), Mariola Sadowska, Robert C. Gallo, Robert Redfield	55
19	Induction of G ₁ cycle arrest in T lymphocytes results in increased extracellular levels of β-chemokines: A strategy to inhibit R5 HIV-1 2003 ·Proceedings of the National Academy of Sciences ·Alonso Heredia, Charles E. Davis, Anthony Amoroso, (unknown), Nhut Le, (unknown), (unknown), Davide Zella, Robert Redfield	26
20	Abacavir in Combination With the Inosine Monophosphate Dehydrogenase (IMPDH)–Inhibitor Mycophenolic Acid Is Active Against Multidrug-Resistant HIV-1 1999 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Alonso Heredia, David M. Margolis, David Oldach, Richard Hazen, Nhut Le, Robert Redfield	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact